|
MTCH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.016700E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.616000E-03 |
| Stage1-vs-Stage3 |
5.177900E-02 |
| Stage1-vs-Stage4 |
1.843270E-03 |
| Stage2-vs-Stage3 |
2.033000E-04 |
| Stage2-vs-Stage4 |
1.96443999999074E-05 |
| Stage3-vs-Stage4 |
2.346000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.76389999962635E-08 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
6.065000E-01 |
| Caucasian-vs-Asian |
1.076460E-02 |
| AfricanAmerican-vs-Asian |
1.236030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.435800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(41-60Yrs) |
3.77475828372553E-15 |
| Normal-vs-Age(61-80Yrs) |
1.73050018759113E-10 |
| Normal-vs-Age(81-100Yrs) |
1.438800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.628200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.821900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.679200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.987000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.616400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.271000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.08039976543762E-10 |
| Classical-VS-Follicular |
6.32150000012821E-07 |
| Classical-VS-Other |
9.447000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.6621374255883E-15 |
| Tall-VS-Other |
1.194220E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.253160E-01 |
| Follicular-VS-Normal |
3.79220000001901E-06 |
| Other-VS-Normal |
1.584960E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.02042851735496E-13 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.01090247284219E-11 |
|
|
